2025 HCPCS Code G9073
Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
TAGS: adenocarcinoma invasive disease carcinoma female demonstration include predominant stage cancer evidence metastases ductal| Short Description | Onc dx brst stg3-hr, no pro |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2006 |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- G9220 - No order for pjp for medrsn
- G9221 - Pjp proph prescribed
- G9222 - Pjp proph ordered low cd4
- G9223 - Pjp proph ordered cd4 low
- G9224 - Medrsn no foot exam
- G9225 - Norsn no foot exam
- G9226 - 3 comp foot exam completed
- G9227 - Foa doc, care plan not doc
- G9228 - Gc chl syp documented
- G9229 - Ptrsn no gc chl syp test
- G9230 - Norsn for gc chl syp test
- G9231 - Doc esrd dia trans preg
- G9232 - Ptrsn no comm comorbid
- G9233 - Tkr composite
- G9234 - Tkr intent
- G9235 - Gs mg composite
- G9236 - Op rad mg composite
- G9237 - Gs mg intent
- G9238 - Op rad mg intent
- G9239 - Doc rsn hemod & cath acc